These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10666681)

  • 1. Oxidative stress and neural dysfunction in Down syndrome.
    Iannello RC; Crack PJ; de Haan JB; Kola I
    J Neural Transm Suppl; 1999; 57():257-67. PubMed ID: 10666681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. App gene dosage modulates endosomal abnormalities of Alzheimer's disease in a segmental trisomy 16 mouse model of down syndrome.
    Cataldo AM; Petanceska S; Peterhoff CM; Terio NB; Epstein CJ; Villar A; Carlson EJ; Staufenbiel M; Nixon RA
    J Neurosci; 2003 Jul; 23(17):6788-92. PubMed ID: 12890772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of amyloid precursor protein normalizes cholinergic function in a cell line derived from the cerebral cortex of a trisomy 16 mouse: An animal model of down syndrome.
    Opazo P; Saud K; de Saint Pierre M; Cárdenas AM; Allen DD; Segura-Aguilar J; Caviedes R; Caviedes P
    J Neurosci Res; 2006 Nov; 84(6):1303-10. PubMed ID: 16941497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using mouse models to explore genotype-phenotype relationship in Down syndrome.
    Salehi A; Faizi M; Belichenko PV; Mobley WC
    Ment Retard Dev Disabil Res Rev; 2007; 13(3):207-14. PubMed ID: 17910089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down syndrome--a gene dosage disease caused by trisomy of genes within a small segment of the long arm of chromosome 21, exemplified by the study of effects from the superoxide-dismutase type 1 (SOD-1) gene.
    Annerén G; Edman B
    APMIS Suppl; 1993; 40():71-9. PubMed ID: 8311993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular abnormalities of the brain in Down syndrome: relevance to Alzheimer's neurodegeneration.
    de la Monte SM
    J Neural Transm Suppl; 1999; 57():1-19. PubMed ID: 10666665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mapping of Alzheimer-type dementia in Down's syndrome.
    Prasher VP; Farrer MJ; Kessling AM; Fisher EM; West RJ; Barber PC; Butler AC
    Ann Neurol; 1998 Mar; 43(3):380-3. PubMed ID: 9506555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial dysfunction and tau hyperphosphorylation in Ts1Cje, a mouse model for Down syndrome.
    Shukkur EA; Shimohata A; Akagi T; Yu W; Yamaguchi M; Murayama M; Chui D; Takeuchi T; Amano K; Subramhanya KH; Hashikawa T; Sago H; Epstein CJ; Takashima A; Yamakawa K
    Hum Mol Genet; 2006 Sep; 15(18):2752-62. PubMed ID: 16891409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of global gene expression and cell proliferation by APP.
    Wu Y; Zhang S; Xu Q; Zou H; Zhou W; Cai F; Li T; Song W
    Sci Rep; 2016 Mar; 6():22460. PubMed ID: 26936520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiling in the adult Down syndrome brain.
    Lockstone HE; Harris LW; Swatton JE; Wayland MT; Holland AJ; Bahn S
    Genomics; 2007 Dec; 90(6):647-60. PubMed ID: 17950572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
    García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
    Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential MRI patterns of brain atrophy in double or single transgenic mice for APP and/or SOD.
    Borg J; Chereul E
    J Neurosci Res; 2008 Nov; 86(15):3275-84. PubMed ID: 18646206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress and Down syndrome. Do antioxidants play a role in therapy?
    Muchová J; Žitňanová I; Ďuračková Z
    Physiol Res; 2014; 63(5):535-42. PubMed ID: 24908086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The brain in Down syndrome.
    Seidl R; Cairns N; Lubec G
    J Neural Transm Suppl; 2001; (61):247-61. PubMed ID: 11771748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration.
    Salehi A; Delcroix JD; Belichenko PV; Zhan K; Wu C; Valletta JS; Takimoto-Kimura R; Kleschevnikov AM; Sambamurti K; Chung PP; Xia W; Villar A; Campbell WA; Kulnane LS; Nixon RA; Lamb BT; Epstein CJ; Stokin GB; Goldstein LS; Mobley WC
    Neuron; 2006 Jul; 51(1):29-42. PubMed ID: 16815330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional and morphological alterations in compound transgenic mice overexpressing Cu/Zn superoxide dismutase and amyloid precursor protein [correction].
    Harris-Cerruti C; Kamsler A; Kaplan B; Lamb B; Segal M; Groner Y
    Eur J Neurosci; 2004 Mar; 19(5):1174-90. PubMed ID: 15016076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-amyloid precursor protein, ETS-2 and collagen alpha 1 (VI) chain precursor, encoded on chromosome 21, are not overexpressed in fetal Down syndrome: further evidence against gene dosage effect.
    Engidawork E; Baiic N; Fountoulakis M; Dierssen M; Greber-Platzer S; Lubec G
    J Neural Transm Suppl; 2001; (61):335-46. PubMed ID: 11771756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down syndrome clinical symptoms are manifested in transfected cells and transgenic mice overexpressing the human Cu/Zn-superoxide dismutase gene.
    Groner Y; Elroy-Stein O; Avraham KB; Yarom R; Schickler M; Knobler H; Rotman G
    J Physiol (Paris); 1990; 84(1):53-77. PubMed ID: 1972759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic mosaicism with increased amyloid precursor protein (APP) gene copy number in single neurons from sporadic Alzheimer's disease brains.
    Bushman DM; Kaeser GE; Siddoway B; Westra JW; Rivera RR; Rehen SK; Yung YC; Chun J
    Elife; 2015 Feb; 4():. PubMed ID: 25650802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome.
    Epstein CJ; Avraham KB; Lovett M; Smith S; Elroy-Stein O; Rotman G; Bry C; Groner Y
    Proc Natl Acad Sci U S A; 1987 Nov; 84(22):8044-8. PubMed ID: 2960971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.